[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EA200600853A1 - Новый кристаллический ангидрат с антихолинергическим действием - Google Patents

Новый кристаллический ангидрат с антихолинергическим действием

Info

Publication number
EA200600853A1
EA200600853A1 EA200600853A EA200600853A EA200600853A1 EA 200600853 A1 EA200600853 A1 EA 200600853A1 EA 200600853 A EA200600853 A EA 200600853A EA 200600853 A EA200600853 A EA 200600853A EA 200600853 A1 EA200600853 A1 EA 200600853A1
Authority
EA
Eurasian Patent Office
Prior art keywords
new crystal
anhydrate
cholinergic effect
treatment
crystal anhydrate
Prior art date
Application number
EA200600853A
Other languages
English (en)
Other versions
EA008587B1 (ru
Inventor
Вальдемар Пфренгле
Петер Зигер
Original Assignee
Бёрингер Ингельхайм Интернациональ Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34530662&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200600853(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Бёрингер Ингельхайм Интернациональ Гмбх filed Critical Бёрингер Ингельхайм Интернациональ Гмбх
Publication of EA200600853A1 publication Critical patent/EA200600853A1/ru
Publication of EA008587B1 publication Critical patent/EA008587B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

В заявке описаны новый кристаллический ангидрат тиотропийбромида, способ его получения, а также его применение для получения лекарственного средства, предназначенного для лечения заболеваний дыхательных путей, прежде всего для лечения хронического обструктивного заболевания легких и астмы.
EA200600853A 2003-11-03 2004-10-29 Новый кристаллический ангидрат с антихолинергическим действием EA008587B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03025077 2003-11-03
PCT/EP2004/012269 WO2005042527A1 (de) 2003-11-03 2004-10-29 Neues kristallines anhydrat mit anticholinerger wirksamkeit

Publications (2)

Publication Number Publication Date
EA200600853A1 true EA200600853A1 (ru) 2006-10-27
EA008587B1 EA008587B1 (ru) 2007-06-29

Family

ID=34530662

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600853A EA008587B1 (ru) 2003-11-03 2004-10-29 Новый кристаллический ангидрат с антихолинергическим действием

Country Status (34)

Country Link
EP (1) EP1682542B1 (ru)
JP (1) JP4553902B2 (ru)
KR (2) KR101285571B1 (ru)
CN (1) CN100509809C (ru)
AR (1) AR046319A1 (ru)
AT (1) ATE453641T1 (ru)
AU (1) AU2004285684B2 (ru)
BR (1) BRPI0415636A (ru)
CA (1) CA2544352C (ru)
CO (1) CO5690641A2 (ru)
CY (1) CY1110339T1 (ru)
DE (1) DE502004010602D1 (ru)
DK (1) DK1682542T3 (ru)
EA (1) EA008587B1 (ru)
EC (1) ECSP066543A (ru)
ES (1) ES2338563T3 (ru)
HK (1) HK1099752A1 (ru)
HR (1) HRP20100029T1 (ru)
IL (1) IL175126A (ru)
ME (1) ME00349B (ru)
MX (1) MX272045B (ru)
MY (1) MY146628A (ru)
NO (1) NO20062569L (ru)
NZ (1) NZ547581A (ru)
PE (1) PE20050996A1 (ru)
PL (1) PL1682542T3 (ru)
PT (1) PT1682542E (ru)
RS (2) RS20060291A (ru)
SI (1) SI1682542T1 (ru)
TW (1) TWI336330B (ru)
UA (1) UA82909C2 (ru)
UY (1) UY28596A1 (ru)
WO (1) WO2005042527A1 (ru)
ZA (1) ZA200602344B (ru)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080007656A (ko) * 2005-05-02 2008-01-22 베링거 인겔하임 인터내셔날 게엠베하 티오트로피움 브로마이드의 신규한 결정질 형태
US9108962B2 (en) 2005-12-19 2015-08-18 Sicor, Inc. Forms of tiotropium bromide and processes for preparation thereof
WO2007075858A2 (en) * 2005-12-19 2007-07-05 Sicor Inc. Novel forms of tiotropium bromide and processes for preparation thereof
RU2453547C2 (ru) * 2005-12-19 2012-06-20 Сикор Инк. Новые формы тиотропия бромида и способы их получения
DE602006020620D1 (de) * 2006-01-04 2011-04-21 Boehringer Ingelheim Pharma Verwendung von tiotropium-salzen bei der behandlung von mässigem persistierendem asthma
CN100999521B (zh) * 2006-01-13 2010-12-08 江苏正大天晴药业股份有限公司 结晶性抗胆碱药噻托溴铵
US20080051582A1 (en) 2006-07-10 2008-02-28 Sicor Inc. Process for the preparation of tiotropium bromide
CN101032484B (zh) * 2007-04-02 2010-05-26 南京卡文迪许生物工程技术有限公司 一种噻托溴铵胶囊型吸入粉雾剂
GB0716026D0 (en) 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
WO2010052450A1 (en) * 2008-11-04 2010-05-14 Cipla Limited Tiotropium bromide having a low degree of crystallinity
BRPI0916047A2 (pt) * 2008-11-04 2015-11-10 Cipla Ltd composição farmacêutica em aerossol, uso de uma composição farmacêutica em aerossol, método para tratamento de sintomas crônicos ou agudos severos, moderados ou leves, ou para tratamento profilático de um distúrbio respiratório, dispensador farmacêutico em aerossol, processo para fabricação de um dispensador farmacêutico em aerossol e processo para fabricação de um complexo de um agente ativo e um adjuvante
CA2768553C (en) * 2009-08-07 2016-08-02 Generics [Uk] Limited Anhydrate of tiotropium bromide
TR201111589A2 (tr) * 2011-03-03 2012-09-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür susuz kristal formu.
CZ304368B6 (cs) 2011-11-28 2014-04-02 Zentiva, K.S. Směsný solvát tiotropium bromidu a způsob jeho přípravy
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
WO2014042605A1 (en) * 2012-09-11 2014-03-20 Mahmut Bilgic New tiotropium bromide crystalline form
HUE032455T2 (en) 2012-11-05 2017-09-28 Zentiva Ks Stabilization of thiotropium solvates
EP2913332A1 (en) 2014-02-27 2015-09-02 Euticals S.P.A. Crystalline form of tiotropium bromide with lactose
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
WO2017138896A1 (en) 2016-02-11 2017-08-17 Sima Patent Ve Lisanslama Hizmetleri Ltd. Şti Crystalline form of tiotropium bromide anhydrate
EP4108230A1 (en) 2021-06-24 2022-12-28 Laboratoires SMB New dry powder composition of tiotropium for inhalation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP1326862B1 (de) * 2000-10-12 2004-09-15 BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO. KG Kristallines monohydrat von tiotropiumbromid, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels
DE10111843A1 (de) * 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von inflammatorischen Erkrankungen
IL159238A0 (en) * 2001-06-22 2004-06-01 Boehringer Ingelheim Pharma Crystalline anticholinergic, method for its production, and use thereof in the production of a drug

Also Published As

Publication number Publication date
ZA200602344B (en) 2007-07-25
KR101285571B1 (ko) 2013-07-15
TWI336330B (en) 2011-01-21
BRPI0415636A (pt) 2006-12-12
EP1682542B1 (de) 2009-12-30
ES2338563T3 (es) 2010-05-10
KR20060121131A (ko) 2006-11-28
DK1682542T3 (da) 2010-05-10
CN1875019A (zh) 2006-12-06
DE502004010602D1 (de) 2010-02-11
TW200526652A (en) 2005-08-16
EP1682542A1 (de) 2006-07-26
NO20062569L (no) 2006-07-12
HRP20100029T1 (hr) 2010-02-28
RS51599B (en) 2011-08-31
EA008587B1 (ru) 2007-06-29
IL175126A (en) 2010-11-30
MY146628A (en) 2012-09-14
SI1682542T1 (sl) 2010-04-30
MEP51708A (en) 2011-02-10
AU2004285684A1 (en) 2005-05-12
MXPA06004940A (es) 2006-07-20
AR046319A1 (es) 2005-11-30
UY28596A1 (es) 2005-06-30
PT1682542E (pt) 2010-01-27
MX272045B (en) 2009-11-23
KR101313904B1 (ko) 2013-09-30
CA2544352C (en) 2013-07-16
HK1099752A1 (en) 2007-08-24
CY1110339T1 (el) 2015-01-14
JP2007509894A (ja) 2007-04-19
UA82909C2 (en) 2008-05-26
KR20120036381A (ko) 2012-04-17
PL1682542T3 (pl) 2010-06-30
CO5690641A2 (es) 2006-10-31
JP4553902B2 (ja) 2010-09-29
IL175126A0 (en) 2006-09-05
ATE453641T1 (de) 2010-01-15
NZ547581A (en) 2009-03-31
WO2005042527A1 (de) 2005-05-12
CA2544352A1 (en) 2005-05-12
ME00349B (me) 2011-05-10
RS20060291A (en) 2008-06-05
CN100509809C (zh) 2009-07-08
AU2004285684B2 (en) 2011-07-14
PE20050996A1 (es) 2005-12-20
ECSP066543A (es) 2006-10-17

Similar Documents

Publication Publication Date Title
EA200600853A1 (ru) Новый кристаллический ангидрат с антихолинергическим действием
UY29506A1 (es) Nuevas formas cristalinas de bromuro de tiotropio
EA200500715A1 (ru) Новые лекарственные средства для лечения хронического обструктивного заболевания лёгких
EA200500902A1 (ru) Порошковые лекарственные средства, содержащие соль тиотропия и ксинафоат салметерола
WO2006117300A3 (en) Crystalline forms of tiotropium bromide
EA200200551A1 (ru) Новые содержащие тиотропий порошки для ингаляции
EA200600854A1 (ru) Новые соли тиотропия, способ их получения, а также содержащие их лекарственные композиции
EA201200876A1 (ru) Новые антагонисты рецептора ccr2 и их применение
DK1718336T3 (da) Ny kombination af anticholinergikum og beta-mimetika til behandling af luftvejssygdomme
EA200401005A1 (ru) Дозированные ингаляторы под давлением, содержащие растворы бета-2-агонистов
DE60334015D1 (de) Pyridopyrrolizin- und pyridoindolizinderivate
WO2007138431A3 (en) Azabicyclic ether histamine-3 antagonists
EA201100942A1 (ru) Циклические пиримидин-4-карбоксамиды в качестве антагонистов рецептора ccr2, предназначенные для лечения воспаления, астмы и хозл
JP2008539268A5 (ru)
DE602005026007D1 (de) Opioide zur behandlung von chronisch-obstruktiver lungenerkrankung (copd)
CY1114157T1 (el) Αλατα του τιοτροπιου, μεθοδος για την παραγωγη τους και φαρμακευτικα σκευασματα που τα περιεχουν
HUP0400222A2 (hu) PDE-4 inhibitort és H1 receptor antagonistát tartalmazó kombináció és ennek alkalmazása tüdőbetegségek kezelésére alkalmas gyógyszerkészítmény előállítására
EP1737499A4 (en) TREATMENT OF CHRONIC OBSTRUCTIVE LUNG DISEASE BY INHALATION OF LOW DOSES OF A PROTEASE HEMMER
EA200500864A1 (ru) Новый, содержащий тиотропий порошковый препарат для ингаляции
NO20082439L (no) Anvendelse av tiotropiumsalter for behandling av moderat vedvarende astma
MEP54208A (en) Medicaments containing steroids and a novel anticholinesterase drug
GT200900044A (es) Polimorfo de bromuro de (r)-3-(2-hidroxi-2,2-difenil-acetoxi)-1-(isoxazol-3-il-carbamoil-metil)-1-azonia-biciclo-[2.2.2]-octano
DE60206391D1 (de) Verwendung von thiazolderivaten zur herstellung eines medikaments zur behandlung von chronischen obstruktiven atemwegserkrankungen
EA200301140A1 (ru) Ингибитор pde4 и антихолинергический агент в комбинации для лечения обструктивных болезней дыхательных путей
BRPI0415685A (pt) sais de tiotrópio, processos para sua produção, bem como formulações de medicamentos contendo os mesmos